- Home
- MKZR vs BRTX Comparison
MKZR vs BRTX Comparison
Compare MKZR & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MKZR | BRTX |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Managed Health Care |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | 3.1M |
| IPO Year | 2012 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MKZR | BRTX |
|---|---|---|
| Price | $1.38 | $2.04 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $160.00 |
| AVG Volume (30 Days) | 6.8K | ★ 22.0K |
| Earning Date | 09-28-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.87 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $20,007,414.00 | $81,000.00 |
| Revenue This Year | N/A | $290.60 |
| Revenue Next Year | N/A | $64.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.83 | $0.14 |
| 52 Week High | $6.00 | $4.10 |
Technical Indicators
Market Signals| Indicator | MKZR | BRTX |
|---|---|---|
| Relative Strength Index (RSI) | 46.44 | 54.86 |
| Support Level | $1.37 | $0.22 |
| Resistance Level | $1.84 | $2.93 |
| Average True Range (ATR) | 0.06 | 0.20 |
| MACD | 0.00 | -0.10 |
| Stochastic Oscillator | 34.78 | 29.42 |
Price Performance
Historical ComparisonAbout MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate. It is a real estate investment manager who utilizes an approach to real estate securities, often seeing opportunities that others overlook. Based in Orinda, California, MacKenzie Capital Management has specialized in discounted real estate securities and asset management.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.